Javascript must be enabled to continue!
Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center
View through CrossRef
Abstract
The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications.
Purpose
Our study aims to reveal the death risk and in-hospital mortality predictors in STEMI patients who develop no-reflow phenomenon after primary percutaneous coronary intervention (PCI).
Material and method
Between 01.01.2016–31.03.2018, we performed a prospective study including 656 patients with STEMI. We included only patients who underwent myocardial revascularization through the primary PCI method and developed no-reflow phenomenon.
Results
Our study included 96 patients with STEMI and no-reflow phenomenon after PCI, of whom 14 died. Mortality rate was significantly higher in subjects with anterior STEMI compared with inferior STEMI (42.9% vs. 14.3%). The mortality registered after PCI was significantly higher in the coronary no-reflow phenomenon group compared with the myocardial no-reflow group (p = 0.039). Post-PCI mortality was significantly higher in patients with complications than in those without complications (33.33% vs. 1.75%, p <0.001).
Conclusions
The coronary no-reflow phenomenon has the highest risk of mortality, accounting for more than half of the myocardial infarction cases compared with the myocardial no-reflow phenomenon. Most of the deaths were reported in subjects with STEMI and the no-reflow phenomenon, who developed cardiovascular complications.
Title: Mortality predictors in patients with ST-segment elevation myocardial infarction presenting no-reflow phenomenon after primary PCI: experience of a tertiary center
Description:
Abstract
The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications.
Purpose
Our study aims to reveal the death risk and in-hospital mortality predictors in STEMI patients who develop no-reflow phenomenon after primary percutaneous coronary intervention (PCI).
Material and method
Between 01.
01.
2016–31.
03.
2018, we performed a prospective study including 656 patients with STEMI.
We included only patients who underwent myocardial revascularization through the primary PCI method and developed no-reflow phenomenon.
Results
Our study included 96 patients with STEMI and no-reflow phenomenon after PCI, of whom 14 died.
Mortality rate was significantly higher in subjects with anterior STEMI compared with inferior STEMI (42.
9% vs.
14.
3%).
The mortality registered after PCI was significantly higher in the coronary no-reflow phenomenon group compared with the myocardial no-reflow group (p = 0.
039).
Post-PCI mortality was significantly higher in patients with complications than in those without complications (33.
33% vs.
1.
75%, p <0.
001).
Conclusions
The coronary no-reflow phenomenon has the highest risk of mortality, accounting for more than half of the myocardial infarction cases compared with the myocardial no-reflow phenomenon.
Most of the deaths were reported in subjects with STEMI and the no-reflow phenomenon, who developed cardiovascular complications.
Related Results
SAFETY AND EFFICACY OF THROMBOLYSIS FOLLOWED BY EARLY PERCUTANEOUS CORONARY INTERVENTION VIA TRANSRADIAL ARTERY APPROACH IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
SAFETY AND EFFICACY OF THROMBOLYSIS FOLLOWED BY EARLY PERCUTANEOUS CORONARY INTERVENTION VIA TRANSRADIAL ARTERY APPROACH IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Objectives
This study was to investigate the safety and efficacy of thrombolysis followed by early PCI via transradial artery approach in patients with ST-segment...
Predictors of Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Sana’a City-Yemen (Single center study)
Predictors of Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Sana’a City-Yemen (Single center study)
Background: Recently, many hospitals in Yemen have been started using Percutaneous Coronary Intervention (PCI) procedure for treatment coronary artery disease (CAD), including Dr. ...
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Objective
Percutaneous Coronary Intervention (PCI) is a technique of cardiac intervention treatment in revascularisation of coronary vessel. The use of PCI in pat...
EFFECTS OF STATIN LOADING BEFORE PRIMARY PCI ON CORONARY ENDOTHELIAL FUNCTION AND INFLAMMATION
EFFECTS OF STATIN LOADING BEFORE PRIMARY PCI ON CORONARY ENDOTHELIAL FUNCTION AND INFLAMMATION
Objectives
The Novel approaches for preventing or limiting events (NAPLIES) and The Atorvastatin for Reduction of Myocardial Damage during Angioplasty (ARMYDA) st...
Managing bifurcations: are two stents better than one?
Managing bifurcations: are two stents better than one?
Abstract
Introduction
Bifurcation percutaneous coronary intervention (PCI) is associated with a higher degree of complexity when...
Early percutaneous coronary intervention after thrombolysis in STEMI: the early-PCI pilot feasibility study
Early percutaneous coronary intervention after thrombolysis in STEMI: the early-PCI pilot feasibility study
Introduction
Primary percutaneous coronary intervention (PCI) is the preferred treatment for patients with STEMI now. But few patients can receive it within 90 mi...
GW24-e3094 Timing of staged percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with multivessel disease
GW24-e3094 Timing of staged percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with multivessel disease
Objectives
Over 50% of ST-segment elevation myocardial infarction (STEMI) patients have multivessel disease, which is known to be associated with worse prognosis....
THE EFFECT OF ATROVASTATIN ON THE QRS DURATION IN THE PATIENTS WITH ACUTE ANTERIOR ST ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY
THE EFFECT OF ATROVASTATIN ON THE QRS DURATION IN THE PATIENTS WITH ACUTE ANTERIOR ST ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY
Objectives
To evaluate the value of intensive atorvastatin treatment on changes of QRS duration and ventricular arrhythmia in the patients with acute anterior ST ...


